TrianglePUBLICATIONS · 26712227
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2016 Feb 10
- First author
- Taverna C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Taverna C
- type
- Author
- name
- Martinelli G
- type
- Author
- name
- Hitz F
- type
- Author
- name
- Mingrone W
- type
- Author
- name
- Pabst T
- type
- Author
- name
- Cevreska L
- type
- Author
- name
- Del Giglio A
- type
- Author
- name
- Vanazzi A
- type
- Author
- name
- Laszlo D
- type
- Author
- name
- Raats J
- type
- Author
- name
- Rauch D
- type
- Author
- name
- Vorobiof DA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Taverna C
- type
- Author
- name
- Martinelli G
- type
- Author
- name
- Hitz F
- type
- Author
- name
- Mingrone W
- type
- Author
- name
- Pabst T
- type
- Author
- name
- Cevreska L
- type
- Author
- name
- Del Giglio A
- type
- Author
- name
- Vanazzi A
- type
- Author
- name
- Laszlo D
- type
- Author
- name
- Raats J
- type
- Author
- name
- Rauch D
- type
- Author
- name
- Vorobiof DA
- type
- Author
- bibliography ids
- nci-bib-781904cb013eab8c815086a5
- book metadata
- content sha256
- 104891d57ef0ffdbd68ec6c61a4bd49c8ab512829c9e4bf19438d6036a1db20a
- document type
- citation
- dois
- 10.1200/JCO.2015.61.3968
- electronic publication date
- display
- 2015 Dec 28
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26712227
- immutable id
- pubmed:26712227@104891d57ef0ffdbd68ec6c61a4bd49c8ab512829c9e4bf19438d6036a1db20a
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 5
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 495-500
- volume
- 34
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26712227
- provenance
- batch id
- 948d34b0dea86780a31d
- provider
- NCBI PubMed ESummary
- record sha256
- dc2981ee493d89fa59f0ddda3a136716e4be376f65d8120720a2dd3800e30ed6
- response sha256
- 11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
- retrieved at
- 2026-09-09T23:47:15.495091+00:00
- publication date
- display
- 2016 Feb 10
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
Preserved source evidence · Independent clinical review pending · Not medical advice